A scientific statement has been published by the ACC regarding the management of obesity in adults with heart failure.

Novartis was expecting a lot from its PARAGON-HF trial of Entresto in heart failure with preserved ejection fraction (HFpEF) and isn’t letting a missed endpoint scupper the programme.

Novo Nordisk has just released the results of the phase 3 STEP-HFpEF trial showing that semaglutide was able to reduce symptoms and improve exercise capacity in overweight people with heart failure.

Tectonic Therapeutic, Inc. (NASDAQ:TECX) is one of the 13 Small Cap Stocks Analysts Are Bullish On. On June 10, Raymond James resumed coverage of Tectonic Therapeutic, Inc. (NASDAQ:TECX) with an ...

We have rounded up the best lenses for astrophotography so you can capture detailed night sky objects and there are savings on the horizon with Prime Day coming on July 8!

A family of Class EF resonant inverters with constant ac voltage output and load-independent characteristics is proposed in this article. Moreover, the design principle of Class EF resonant topologies ...